Spero Therapeutics, Inc. (SPRO)
2.385
-0.02
(-1.04%)
USD |
NASDAQ |
Jan 20, 16:00
2.385
0.00 (0.00%)
After-Hours: 16:13
Spero Therapeutics Market Cap: 134.37M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioMarin Pharmaceutical, Inc. | 10.82B |
| Amicus Therapeutics, Inc. | 4.417B |
| Cassava Sciences, Inc. | 96.62M |
| Omeros Corp. | 868.54M |
| GeoVax Labs, Inc. | 4.850M |
Market Cap Related Metrics
| PS Ratio | 4.520 |
| Price to Book Value | 5.072 |
| Price | 2.385 |
| Earnings Yield | -33.33% |